YCT529 is an experimental non-hormonal male contraceptive developed by YourChoice Therapeutics. It functions as a selective antagonist of the retinoic acid receptor alpha (RAR-α), a nuclear receptor involved in vitamin A signaling.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.